메뉴 건너 뛰기
SinilPharm

수출

수출

ODM 신사업

R&D Pipelines

RESEARCH CODE/APIs CATEGORY STAGE REMARK
Medicinal natural products SI-000413 Osteoarthritis Phase II Licensing out to DongA Pharm.
SI-000902 Rheumatoid Arthritis Phase II IND of Phase II approved
SI-000701 Anticancer Screening
Incrementally modified drugs SI-000513 Osteoporosis Pre-clinical completed Improvement of absorption rate (Bisphosphonates XA)
SI-001002 Peptic ulcer Sustained release form
Biobetter Anti-EGFR Antibody Anticancer Lead optimization Cetuximab biobetter
New transdermal preparations Rivastigmine 27mg Dementia Formulation completed Others: Refer to 5-3.
Super Generic products Valsartan Hypertension Launched Others:Refer to 4.40 BE Tested products
Atorvastatin calcium Hyperlipidemia
Rabeprazole sodium Gastric ulcer
Thioctic acid HR 600mg Diabetes
Risedronate sodium 150mg… Osteoporosis